137 related articles for article (PubMed ID: 6241292)
1. Lack of spontaneous and inducible natural killer cell activity in human bone marrow: presence of adherent suppressor cells.
Uchida A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):181-92. PubMed ID: 6241292
[TBL] [Abstract][Full Text] [Related]
2. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
3. Generation of NK cell activity from human bone marrow.
Lotzová E; Savary CA
J Immunol; 1987 Jul; 139(1):279-84. PubMed ID: 3495600
[TBL] [Abstract][Full Text] [Related]
4. Characterization of natural killer cells cultured from human bone marrow cells.
Yoda Y; Kawakami Z; Shibuya A; Abe T
Exp Hematol; 1988 Sep; 16(8):712-7. PubMed ID: 3042444
[TBL] [Abstract][Full Text] [Related]
5. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Vujanovic NL; Rabinowich H; Lee YJ; Jost L; Herberman RB; Whiteside TL
Cell Immunol; 1993 Oct; 151(1):133-57. PubMed ID: 8402925
[TBL] [Abstract][Full Text] [Related]
6. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
Azuma E; Kaplan J
J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes.
Bloom ET; Babbitt JT
Nat Immun Cell Growth Regul; 1990; 9(1):36-48. PubMed ID: 2139495
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
[TBL] [Abstract][Full Text] [Related]
10. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
12. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
13. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
Klingemann HG; Deal H; Reid D; Eaves CJ
Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
[TBL] [Abstract][Full Text] [Related]
15. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
[TBL] [Abstract][Full Text] [Related]
16. Low natural killer cell activity in the bone marrow of healthy donors with normal killer cell activity in the peripheral blood.
Talpaz M; Spitzer G
Exp Hematol; 1984 Sep; 12(8):629-32. PubMed ID: 6489474
[TBL] [Abstract][Full Text] [Related]
17. Development of natural killer cells in human thymocyte culture: regulation by accessory cells.
Blue ML; Levine H; Daley JF; Craig KA; Schlossman SF
Eur J Immunol; 1987 May; 17(5):669-73. PubMed ID: 3495443
[TBL] [Abstract][Full Text] [Related]
18. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory activity of human bone marrow. Identification of suppressor cells possessing OKM1, SSEA-1, and HNK-1 antigens.
Mortari F; Bains MA; Singhal SK
J Immunol; 1986 Aug; 137(4):1133-7. PubMed ID: 2874177
[TBL] [Abstract][Full Text] [Related]
20. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
